Preface How can we stop cancer progression? Current strategies depend on modeling progression as the balanced outcome of mutations in, and expression of, tumor suppressor genes and oncogenes. New treatments emerge from successful attempts to tip that balance, but secondary mutational escape from those treatments has become a major impediment because it leads to resistance. In this Opinion artic...